Dermatology, Tallaght University Hospital, Dublin, Ireland
Dermatology, Tallaght University Hospital, Dublin, Ireland.
BMJ Case Rep. 2021 Jan 28;14(1):e240863. doi: 10.1136/bcr-2020-240863.
The COVID-19 pandemic has resulted in an incomparable disease burden worldwide. One of the main contributors stems from the multisystem inflammatory syndrome associated with SARS-CoV-2 infection. The numbers of those affected continue to rise with the increasing number of confirmed COVID-19 cases. However, we are yet to fully comprehend the risk factors, disease progression and prognosis for individuals affected. We describe a case of a previously healthy 17-year-old boy who tested positive for the SARS-CoV-2 virus. He presented with a 5-day history of mild influenza-like symptoms, however, quickly required ventilatory support in the intensive care unit. Two months postdischarge, he developed an isolated petechial rash on his palms and soles. His cutaneous presentation was in association with a mixed sensorimotor peripheral neuropathy, debilitating neuropathic pain and intermittent respiratory distress. We postulate that cutaneous manifestations post-COVID-19 could be indicatory of the newly identified multisystem inflammatory syndrome.
COVID-19 大流行在全球造成了无与伦比的疾病负担。其中一个主要原因是与 SARS-CoV-2 感染相关的多系统炎症综合征。随着确诊 COVID-19 病例的增加,受影响的人数继续上升。然而,我们仍未完全了解受影响个体的风险因素、疾病进展和预后。我们描述了一例先前健康的 17 岁男孩,他的 SARS-CoV-2 病毒检测呈阳性。他出现了 5 天的轻度流感样症状,但很快在重症监护室需要呼吸机支持。出院后 2 个月,他的手掌和脚底出现孤立性瘀点皮疹。他的皮肤表现与混合感觉运动性周围神经病、使人衰弱的神经痛和间歇性呼吸窘迫有关。我们推测 COVID-19 后的皮肤表现可能表明存在新发现的多系统炎症综合征。